Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 28, 2009; 15(44): 5598-5603
Published online Nov 28, 2009. doi: 10.3748/wjg.15.5598
Published online Nov 28, 2009. doi: 10.3748/wjg.15.5598
Table 3 OR of risk factors, presented as OR (95% CI)
Model1 | Model 1 | Model 2 | Model 3 |
Both obesity and elevated ALT | - | - | 4.3 (2.7-6.8) |
Obesity | 2.52 (1.7-3.6) | 3.02 (2.1-4.2 ) | - |
Elevated ALT | 2.12 (1.4-3.0) | 2.12 (1.5-2.9) | - |
Metabolic syndrome | - | 2.62 (1.8-3.7) | 3.6 (2.6-5.0) |
Abdominal obesity | 1.62 (1.2-2.2) | - | - |
Elevated blood pressure | 1.72 (1.2-2.4) | - | - |
Elevated fasting glucose | 2.82 (1.8-4.4) | - | - |
Elevated triglyceride | 2.22 (1.6-3.1) | - | - |
Hypo-HDL cholesterolemia | 1.62 (1.1-2.2) | - | - |
Alcohol consumption | 1.2 (0.8-1.7) | 1.2 (0.8-1.6) | 1.2 (0.9-1.7) |
Cigarette smoking | 0.9 (0.7-1.2) | 0.9 (0.6-1.2) | 0.9 (0.6-1.2) |
- Citation: Chen PH, Chen JD, Lin YC. A better parameter in predicting insulin resistance: Obesity plus elevated alanine aminotransferase. World J Gastroenterol 2009; 15(44): 5598-5603
- URL: https://www.wjgnet.com/1007-9327/full/v15/i44/5598.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5598